2. Academic Validation
  3. Novel platinum(IV) complexes trigger apoptosis and ferroptosis to conquer cisplatin resistance in triple-negative breast cancer

Novel platinum(IV) complexes trigger apoptosis and ferroptosis to conquer cisplatin resistance in triple-negative breast cancer

  • Bioorg Chem. 2026 Jun 5:173:109658. doi: 10.1016/j.bioorg.2026.109658.
Guoxiu Cao 1,  Xianjie Ma 2,  Junjie Zhou 1,  Jingguo Qin 3,  Bin Zhang 4,  Xiaochao Huang 5,  Zhikun Liu 6
Affiliations

Affiliations

  • 1 Jiangsu Key Laboratory of Regional Specific Resource Pharmaceutical Transformation, Green Chemistry and Process Enhancement Technology, Huaiyin Institute of Technology, Huai'an 223003, China.
  • 2 Rizhao People's Hospital, No. 126 Tai'an Road, Donggang District, Rizhao 267826, China.
  • 3 Jiangsu Jitai Peptide Technology Co., Ltd, No. 799-2 Xin'an Avenue, Binhai Medical Industrial Park, Binhai, 224500, China.
  • 4 Affiliated Zhumadian Central Hospital of Huanghuai University, Zhumadian 463000, China. Electronic address: zhbin308@163.com.
  • 5 Jiangsu Key Laboratory of Regional Specific Resource Pharmaceutical Transformation, Green Chemistry and Process Enhancement Technology, Huaiyin Institute of Technology, Huai'an 223003, China. Electronic address: viphuangxc@126.com.
  • 6 Jiangsu Key Laboratory of Regional Specific Resource Pharmaceutical Transformation, Green Chemistry and Process Enhancement Technology, Huaiyin Institute of Technology, Huai'an 223003, China. Electronic address: ytdxliuzhikun1@163.com.
PMID: 41722376 DOI: 10.1016/j.bioorg.2026.109658
Abstract

Platinum (II)-based agents are commonly used for the Cancer treatment, but are limited by drug resistance and severe systemic toxicity. To address these limitations, sulfasalazine derivatives were employed as ligands to construct four platinum(IV) complexes, which exhibited superior Anticancer activity compared to cisplatin (CDDP) and oxaliplatin (OXA) against those tested Cancer cells. Among them, the optimal complex 14 can efficiently reverse CDDP resistance in MDA-MB-231 cells. Stability assays confirmed that 14 underwent efficient activation by ascorbic acid to release OXA and 11. Mechanistic studies revealed that the enhanced intracellular uptake of 14 efficiently triggered Apoptosis via inducing DNA damage, increasing intracellular ROS accumulation and activating mitochondrial pathways. Notably, unlike OXA, 14 efficiently induced Ferroptosis through increasing lipid peroxidation, and disrupting cystine/glutamate transporter-glutathione peroxidase axis signaling pathways transduction. Furthermore, 14 significantly suppresses tumor growth in MDA-MB-231/CDDP xenografts without inducing obvious toxicity. Given its high Anticancer activity, complex 14 represents a promising therapeutic candidate for triple-negative breast Cancer treatment.

Keywords

Ferroptosis; Overcome cisplatin resistance; Platinum(IV) complexes; Triple-negative breast cancer.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z